Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SANDOZ DOLUTEGRAVIR DIN 02501457

Status: Approved
Holder: SANDOZ CANADA INCORPORATED
Molecule: DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)

Health Canada record

Active ingredient(s)DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ05AJ03 DOLUTEGRAVIR
Original market date
Current status date29-Apr-2026
SourceHealth Canada DPD

Establishment licence of the holder

Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)

DINProductCompanyFormStrengthStatus
02491753DOVATOVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; LAMIVUDINE 300 MGMarketed
02475774JULUCAVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; RILPIVIRINE (RILPIVIRINE HYDROCHLORIDE) 25 MGMarketed
02556782PMS-DOLUTEGRAVIRPHARMASCIENCE INCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MGMarketed
02511517TIVICAYVIIV HEALTHCARE ULCTablet For SuspensionDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 5 MGMarketed
02414945TIVICAYVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MGMarketed
02430932TRIUMEQVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 50 MG; ABACAVIR (ABACAVIR SULFATE) 600 MG; LAMIVUDINE 300 MGMarketed
02461226TIVICAYVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 25 MGCancelled Post Market
02461218TIVICAYVIIV HEALTHCARE ULCTabletDOLUTEGRAVIR (DOLUTEGRAVIR SODIUM) 10 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
374252026-04-29Abbreviated New Drug Submission (ANDS)
Request a quote for SANDOZ DOLUTEGRAVIR

How to read a Canadian DIN record